- Home
- TLS vs CVRX Comparison
TLS vs CVRX Comparison
Compare TLS & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLS
- CVRX
- Stock Information
- Founded
- TLS 1969
- CVRX 2000
- Country
- TLS United States
- CVRX United States
- Employees
- TLS 519
- CVRX N/A
- Industry
- TLS EDP Services
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- TLS Technology
- CVRX Health Care
- Exchange
- TLS Nasdaq
- CVRX Nasdaq
- Market Cap
- TLS 209.4M
- CVRX 174.4M
- IPO Year
- TLS 2020
- CVRX 2021
- Fundamental
- Price
- TLS $2.73
- CVRX $8.66
- Analyst Decision
- TLS Buy
- CVRX Buy
- Analyst Count
- TLS 6
- CVRX 7
- Target Price
- TLS $3.94
- CVRX $14.50
- AVG Volume (30 Days)
- TLS 673.5K
- CVRX 268.8K
- Earning Date
- TLS 08-08-2025
- CVRX 08-04-2025
- Dividend Yield
- TLS N/A
- CVRX N/A
- EPS Growth
- TLS N/A
- CVRX N/A
- EPS
- TLS N/A
- CVRX N/A
- Revenue
- TLS $109,269,000.00
- CVRX $52,870,000.00
- Revenue This Year
- TLS $35.76
- CVRX $11.53
- Revenue Next Year
- TLS $26.83
- CVRX $18.61
- P/E Ratio
- TLS N/A
- CVRX N/A
- Revenue Growth
- TLS N/A
- CVRX 25.62
- 52 Week Low
- TLS $1.83
- CVRX $4.30
- 52 Week High
- TLS $4.82
- CVRX $18.55
- Technical
- Relative Strength Index (RSI)
- TLS 44.26
- CVRX 64.24
- Support Level
- TLS $2.79
- CVRX $8.15
- Resistance Level
- TLS $2.93
- CVRX $8.63
- Average True Range (ATR)
- TLS 0.15
- CVRX 0.56
- MACD
- TLS -0.02
- CVRX 0.06
- Stochastic Oscillator
- TLS 14.29
- CVRX 85.85
About TLS Telos Corporation
Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.